<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35951510</PMID><DateCompleted><Year>2022</Year><Month>08</Month><Day>15</Day></DateCompleted><DateRevised><Year>2022</Year><Month>09</Month><Day>02</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><Issue>8</Issue><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Network diffusion model predicts neurodegeneration in limb-onset Amyotrophic Lateral Sclerosis.</ArticleTitle><Pagination><StartPage>e0272736</StartPage><MedlinePgn>e0272736</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0272736</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0272736</ELocationID><Abstract><AbstractText Label="OBJECTIVE">Emerging evidences suggest that the trans-neural propagation of phosphorylated 43-kDa transactive response DNA-binding protein (pTDP-43) contributes to neurodegeneration in Amyotrophic Lateral Sclerosis (ALS). We investigated whether Network Diffusion Model (NDM), a biophysical model of spread of pathology via the brain connectome, could capture the severity and progression of neurodegeneration (atrophy) in ALS.</AbstractText><AbstractText Label="METHODS">We measured degeneration in limb-onset ALS patients (n = 14 at baseline, 12 at 6-months, and 9 at 12 months) and controls (n = 12 at baseline) using FreeSurfer analysis on the structural T1-weighted Magnetic Resonance Imaging (MRI) data. The NDM was simulated on the canonical structural connectome from the IIT Human Brain Atlas. To determine whether NDM could predict the atrophy pattern in ALS, the accumulation of pathology modelled by NDM was correlated against atrophy measured using MRI. In order to investigate whether network spread on the brain connectome derived from healthy individuals were significant findings, we compared our findings against network spread simulated on random networks.</AbstractText><AbstractText Label="RESULTS">The cross-sectional analyses revealed that the network diffusion seeded from the inferior frontal gyrus (pars triangularis and pars orbitalis) significantly predicts the atrophy pattern in ALS compared to controls. Whereas, atrophy over time with-in the ALS group was best predicted by seeding the network diffusion process from the inferior temporal gyrus at 6-month and caudal middle frontal gyrus at 12-month. Network spread simulated on the random networks showed that the findings using healthy brain connectomes are significantly different from null models.</AbstractText><AbstractText Label="INTERPRETATION">Our findings suggest the involvement of extra-motor regions in seeding the spread of pathology in ALS. Importantly, NDM was able to recapitulate the dynamics of pathological progression in ALS. Understanding the spatial shifts in the seeds of degeneration over time can potentially inform further research in the design of disease modifying therapeutic interventions in ALS.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bhattarai</LastName><ForeName>Anjan</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-9178-6509</Identifier><AffiliationInfo><Affiliation>Department of Psychiatry, Monash University, Clayton, Victoria, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Monash Biomedical Imaging, Monash University, Clayton, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Zhaolin</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Monash Biomedical Imaging, Monash University, Clayton, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chua</LastName><ForeName>Phyllis</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Monash University, Clayton, Victoria, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Statewide Progressive Neurological Disease Service, Calvary Health Care Bethlehem, South Caulfield, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Talman</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>School of Medicine, Faculty of Health, Deakin University, Geelong, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mathers</LastName><ForeName>Susan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Statewide Progressive Neurological Disease Service, Calvary Health Care Bethlehem, South Caulfield, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chapman</LastName><ForeName>Caron</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Neurosciences Department, University Hospital, Geelong, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Howe</LastName><ForeName>James</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Statewide Progressive Neurological Disease Service, Calvary Health Care Bethlehem, South Caulfield, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>C M Sarah</ForeName><Initials>CMS</Initials><AffiliationInfo><Affiliation>Statewide Progressive Neurological Disease Service, Calvary Health Care Bethlehem, South Caulfield, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lie</LastName><ForeName>Yenni</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Statewide Progressive Neurological Disease Service, Calvary Health Care Bethlehem, South Caulfield, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Poudel</LastName><ForeName>Govinda R</ForeName><Initials>GR</Initials><AffiliationInfo><Affiliation>Mary MacKillop Institute for Health Research, Australian Catholic University, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Egan</LastName><ForeName>Gary F</ForeName><Initials>GF</Initials><AffiliationInfo><Affiliation>Monash Biomedical Imaging, Monash University, Clayton, Victoria, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>08</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001284" MajorTopicYN="N">Atrophy</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D063132" MajorTopicYN="Y">Connectome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>12</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>7</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>8</Month><Day>11</Day><Hour>13</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>8</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>8</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35951510</ArticleId><ArticleId IdType="pmc">PMC9371353</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0272736</ArticleId><ArticleId IdType="pii">PONE-D-21-38767</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kiernan MC, Vucic S, Cheah BC, Turner MR, Eisen A, Hardiman O, et al.. Amyotrophic lateral sclerosis. Lancet. 2011;377(9769):942&#x2013;55. doi: 10.1016/S0140-6736(10)61156-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(10)61156-7</ArticleId><ArticleId IdType="pubmed">21296405</ArticleId></ArticleIdList></Reference><Reference><Citation>Foerster BR, Welsh RC, Feldman EL. 25 years of neuroimaging in amyotrophic lateral sclerosis. Nat Rev Neurol. 2013;9(9):513&#x2013;24. doi: 10.1038/nrneurol.2013.153</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2013.153</ArticleId><ArticleId IdType="pmc">PMC4182931</ArticleId><ArticleId IdType="pubmed">23917850</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S, Melhem ER, Poptani H, Woo JH. Neuroimaging in amyotrophic lateral sclerosis. Neurotherapeutics. 2011;8(1):63&#x2013;71. doi: 10.1007/s13311-010-0011-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13311-010-0011-3</ArticleId><ArticleId IdType="pmc">PMC3075738</ArticleId><ArticleId IdType="pubmed">21274686</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonafede R, Mariotti R. ALS Pathogenesis and Therapeutic Approaches: The Role of Mesenchymal Stem Cells and Extracellular Vesicles. Frontiers in Cellular Neuroscience. 2017;11. doi: 10.3389/fncel.2017.00080</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2017.00080</ArticleId><ArticleId IdType="pmc">PMC5359305</ArticleId><ArticleId IdType="pubmed">28377696</ArticleId></ArticleIdList></Reference><Reference><Citation>Carri MT, Ferri A, Cozzolino M, Calabrese L, Rotilio G. Neurodegeneration in amyotrophic lateral sclerosis: the role of oxidative stress and altered homeostasis of metals. Brain research bulletin. 2003;61(4):365&#x2013;74. doi: 10.1016/s0361-9230(03)00179-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0361-9230(03)00179-5</ArticleId><ArticleId IdType="pubmed">12909279</ArticleId></ArticleIdList></Reference><Reference><Citation>Riku Y. Reappraisal of the anatomical spreading and propagation hypothesis about TDP-43 aggregation in amyotrophic lateral sclerosis and frontotemporal lobar degeneration. Neuropathology. 2020;40(5):426&#x2013;35. doi: 10.1111/neup.12644</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/neup.12644</ArticleId><ArticleId IdType="pubmed">32157757</ArticleId></ArticleIdList></Reference><Reference><Citation>Jo M, Lee S, Jeon Y-M, Kim S, Kwon Y, Kim H-J. The role of TDP-43 propagation in neurodegenerative diseases: integrating insights from clinical and experimental studies. Experimental &amp; Molecular Medicine. 2020;52(10):1652&#x2013;62. doi: 10.1038/s12276-020-00513-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s12276-020-00513-7</ArticleId><ArticleId IdType="pmc">PMC8080625</ArticleId><ArticleId IdType="pubmed">33051572</ArticleId></ArticleIdList></Reference><Reference><Citation>Braak H, Brettschneider J, Ludolph AC, Lee VM, Trojanowski JQ, Del Tredici K. Amyotrophic lateral sclerosis&#x2014;a model of corticofugal axonal spread. Nature reviews Neurology. 2013;9(12):708&#x2013;14. doi: 10.1038/nrneurol.2013.221</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2013.221</ArticleId><ArticleId IdType="pmc">PMC3943211</ArticleId><ArticleId IdType="pubmed">24217521</ArticleId></ArticleIdList></Reference><Reference><Citation>Braak H, Ludolph AC, Neumann M, Ravits J, Del Tredici K. Pathological TDP-43 changes in Betz cells differ from those in bulbar and spinal &#x3b1;-motoneurons in sporadic amyotrophic lateral sclerosis. Acta neuropathologica. 2017;133(1):79&#x2013;90. doi: 10.1007/s00401-016-1633-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-016-1633-2</ArticleId><ArticleId IdType="pmc">PMC5209403</ArticleId><ArticleId IdType="pubmed">27757524</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaunmuktane Z, Brandner S. Invited Review: The role of prion-like mechanisms in neurodegenerative diseases. Neuropathology and Applied Neurobiology. 2020;46(6):522&#x2013;45. doi: 10.1111/nan.12592</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nan.12592</ArticleId><ArticleId IdType="pmc">PMC7687189</ArticleId><ArticleId IdType="pubmed">31868945</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou J, Gennatas ED, Kramer JH, Miller BL, Seeley WW. Predicting regional neurodegeneration from the healthy brain functional connectome. Neuron. 2012;73(6):1216&#x2013;27. doi: 10.1016/j.neuron.2012.03.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2012.03.004</ArticleId><ArticleId IdType="pmc">PMC3361461</ArticleId><ArticleId IdType="pubmed">22445348</ArticleId></ArticleIdList></Reference><Reference><Citation>Raj A, Kuceyeski A, Weiner M. A network diffusion model of disease progression in dementia. Neuron. 2012;73(6):1204&#x2013;15. doi: 10.1016/j.neuron.2011.12.040</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.12.040</ArticleId><ArticleId IdType="pmc">PMC3623298</ArticleId><ArticleId IdType="pubmed">22445347</ArticleId></ArticleIdList></Reference><Reference><Citation>Poudel GR, Harding IH, Egan GF, Georgiou-Karistianis N. Network spread determines severity of degeneration and disconnection in Huntington&#x2019;s disease. Human Brain Mapping. 2019;40(14):4192&#x2013;201. doi: 10.1002/hbm.24695</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hbm.24695</ArticleId><ArticleId IdType="pmc">PMC6865500</ArticleId><ArticleId IdType="pubmed">31187915</ArticleId></ArticleIdList></Reference><Reference><Citation>Raj A, LoCastro E, Kuceyeski A, Tosun D, Relkin N, Weiner M. Network Diffusion Model of Progression Predicts Longitudinal Patterns of Atrophy and Metabolism in Alzheimer&#x2019;s Disease. Cell reports. 2015;10(3):359&#x2013;69. doi: 10.1016/j.celrep.2014.12.034</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2014.12.034</ArticleId><ArticleId IdType="pmc">PMC5747552</ArticleId><ArticleId IdType="pubmed">25600871</ArticleId></ArticleIdList></Reference><Reference><Citation>Pandya S, Zeighami Y, Freeze B, Dadar M, Collins DL, Dagher A, et al.. Predictive model of spread of Parkinson&#x2019;s pathology using network diffusion. NeuroImage. 2019;192:178&#x2013;94. doi: 10.1016/j.neuroimage.2019.03.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroimage.2019.03.001</ArticleId><ArticleId IdType="pmc">PMC7180066</ArticleId><ArticleId IdType="pubmed">30851444</ArticleId></ArticleIdList></Reference><Reference><Citation>Poudel GR, Dominguez DJ, Verhelst H, Vander Linden C, Deblaere K, Jones DK, et al.. Network diffusion modeling predicts neurodegeneration in traumatic brain injury. Ann Clin Transl Neurol. 2020;7(3):270&#x2013;9. doi: 10.1002/acn3.50984</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.50984</ArticleId><ArticleId IdType="pmc">PMC7086000</ArticleId><ArticleId IdType="pubmed">32105414</ArticleId></ArticleIdList></Reference><Reference><Citation>Meier JM, van der Burgh HK, Nitert AD, Bede P, de Lange SC, Hardiman O, et al.. Connectome-Based Propagation Model in Amyotrophic Lateral Sclerosis. Ann Neurol. 2020;87(5):725&#x2013;38. doi: 10.1002/ana.25706</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.25706</ArticleId><ArticleId IdType="pmc">PMC7186838</ArticleId><ArticleId IdType="pubmed">32072667</ArticleId></ArticleIdList></Reference><Reference><Citation>Pandya S, Maia PD, Freeze B, Menke RAL, Talbot K, Turner MR, et al.. Modelling seeding and neuroanatomic spread of pathology in amyotrophic lateral sclerosis. bioRxiv. 2021:2021.02.24.431118.</Citation><ArticleIdList><ArticleId IdType="pubmed">35143975</ArticleId></ArticleIdList></Reference><Reference><Citation>Qi X, Arfanakis K. Regionconnect: Rapidly extracting standardized brain connectivity information in voxel-wise neuroimaging studies. NeuroImage. 2021;225:117462. doi: 10.1016/j.neuroimage.2020.117462</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroimage.2020.117462</ArticleId><ArticleId IdType="pmc">PMC7811895</ArticleId><ArticleId IdType="pubmed">33075560</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischl B. FreeSurfer. NeuroImage. 2012;62(2):774&#x2013;81. doi: 10.1016/j.neuroimage.2012.01.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroimage.2012.01.021</ArticleId><ArticleId IdType="pmc">PMC3685476</ArticleId><ArticleId IdType="pubmed">22248573</ArticleId></ArticleIdList></Reference><Reference><Citation>Reuter M, Schmansky NJ, Rosas HD, Fischl B. Within-subject template estimation for unbiased longitudinal image analysis. NeuroImage. 2012;61(4):1402&#x2013;18. doi: 10.1016/j.neuroimage.2012.02.084</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroimage.2012.02.084</ArticleId><ArticleId IdType="pmc">PMC3389460</ArticleId><ArticleId IdType="pubmed">22430496</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitwell JL, Crum WR, Watt HC, Fox NC. Normalization of cerebral volumes by use of intracranial volume: implications for longitudinal quantitative MR imaging. American Journal of Neuroradiology. 2001;22(8):1483&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7974589</ArticleId><ArticleId IdType="pubmed">11559495</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhattarai A, Chen Z, Ward PGD, Talman P, Mathers S, Phan TG, et al.. Serial assessment of iron in the motor cortex in limb-onset amyotrophic lateral sclerosis using quantitative susceptibility mapping. Quant Imaging Med Surg. 2020;10(7):1465&#x2013;76. doi: 10.21037/qims-20-187</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/qims-20-187</ArticleId><ArticleId IdType="pmc">PMC7358415</ArticleId><ArticleId IdType="pubmed">32676365</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhattarai A, Egan GF, Talman P, Chua P, Chen Z. Magnetic Resonance Iron Imaging in Amyotrophic Lateral Sclerosis. Journal of Magnetic Resonance Imaging. 2021;n/a(n/a). doi: 10.1002/jmri.27530</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmri.27530</ArticleId><ArticleId IdType="pubmed">33586315</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A, Pagani M, Agosta F, Calvo A, Cistaro A, Filippi M. Neuroimaging in amyotrophic lateral sclerosis: insights into structural and functional changes. The Lancet Neurology. 2014;13(12):1228&#x2013;40. doi: 10.1016/S1474-4422(14)70167-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(14)70167-X</ArticleId><ArticleId IdType="pubmed">25453462</ArticleId></ArticleIdList></Reference><Reference><Citation>Agosta F, Pagani E, Rocca MA, Caputo D, Perini M, Salvi F, et al.. Voxel-based morphometry study of brain volumetry and diffusivity in amyotrophic lateral sclerosis patients with mild disability. Human brain mapping. 2007;28(12):1430&#x2013;8. doi: 10.1002/hbm.20364</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hbm.20364</ArticleId><ArticleId IdType="pmc">PMC6871473</ArticleId><ArticleId IdType="pubmed">17370339</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner MR, Hammers A, Allsop J, Al-Chalabi A, Shaw CE, Brooks DJ, et al.. Volumetric cortical loss in sporadic and familial amyotrophic lateral sclerosis. Amyotrophic lateral sclerosis: official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases. 2007;8(6):343&#x2013;7. doi: 10.1080/17482960701538734</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17482960701538734</ArticleId><ArticleId IdType="pubmed">18033592</ArticleId></ArticleIdList></Reference><Reference><Citation>Mezzapesa DM, Ceccarelli A, Dicuonzo F, Carella A, De Caro MF, Lopez M, et al.. Whole-brain and regional brain atrophy in amyotrophic lateral sclerosis. AJNR American journal of neuroradiology. 2007;28(2):255&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7977419</ArticleId><ArticleId IdType="pubmed">17296989</ArticleId></ArticleIdList></Reference><Reference><Citation>Abrahams S, Goldstein LH, Suckling J, Ng V, Simmons A, Chitnis X, et al.. Frontotemporal white matter changes in amyotrophic lateral sclerosis. Journal of neurology. 2005;252(3):321&#x2013;31. doi: 10.1007/s00415-005-0646-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-005-0646-x</ArticleId><ArticleId IdType="pubmed">15739047</ArticleId></ArticleIdList></Reference><Reference><Citation>Thorns J, Jansma H, Peschel T, Grosskreutz J, Mohammadi B, Dengler R, et al.. Extent of cortical involvement in amyotrophic lateral sclerosis&#x2014;an analysis based on cortical thickness. BMC Neurol. 2013;13:148. doi: 10.1186/1471-2377-13-148</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2377-13-148</ArticleId><ArticleId IdType="pmc">PMC3853794</ArticleId><ArticleId IdType="pubmed">24138960</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng L, Yuan Y, Tang X, Zhou Y, Luo C, Liu D, et al.. Structural and functional underpinnings of precentral abnormalities in amyotrophic lateral sclerosis. European Journal of Neurology. 2021;28(5):1528&#x2013;36. doi: 10.1111/ene.14717</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14717</ArticleId><ArticleId IdType="pubmed">33404153</ArticleId></ArticleIdList></Reference><Reference><Citation>Verstraete E, Veldink JH, Hendrikse J, Schelhaas HJ, van den Heuvel MP, van den Berg LH. Structural MRI reveals cortical thinning in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2012;83(4):383&#x2013;8. doi: 10.1136/jnnp-2011-300909</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2011-300909</ArticleId><ArticleId IdType="pubmed">21965521</ArticleId></ArticleIdList></Reference><Reference><Citation>Agosta F, Gorno-Tempini ML, Pagani E, Sala S, Caputo D, Perini M, et al.. Longitudinal assessment of grey matter contraction in amyotrophic lateral sclerosis: A tensor based morphometry study. Amyotroph Lateral Scler. 2009;10(3):168&#x2013;74. doi: 10.1080/17482960802603841</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17482960802603841</ArticleId><ArticleId IdType="pubmed">19058055</ArticleId></ArticleIdList></Reference><Reference><Citation>Senda J, Kato S, Kaga T, Ito M, Atsuta N, Nakamura T, et al.. Progressive and widespread brain damage in ALS: MRI voxel-based morphometry and diffusion tensor imaging study. Amyotroph Lateral Scler. 2011;12(1):59&#x2013;69. doi: 10.3109/17482968.2010.517850</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2010.517850</ArticleId><ArticleId IdType="pubmed">21271792</ArticleId></ArticleIdList></Reference><Reference><Citation>Paganoni S, Macklin EA, Lee A, Murphy A, Chang J, Zipf A, et al.. Diagnostic timelines and delays in diagnosing amyotrophic lateral sclerosis (ALS). Amyotroph Lateral Scler Frontotemporal Degener. 2014;15(5&#x2013;6):453&#x2013;6. doi: 10.3109/21678421.2014.903974</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2014.903974</ArticleId><ArticleId IdType="pmc">PMC4433003</ArticleId><ArticleId IdType="pubmed">24981792</ArticleId></ArticleIdList></Reference><Reference><Citation>Brettschneider J, Del Tredici K, Toledo JB, Robinson JL, Irwin DJ, Grossman M, et al.. Stages of pTDP-43 pathology in amyotrophic lateral sclerosis. Ann Neurol. 2013;74(1):20&#x2013;38. doi: 10.1002/ana.23937</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.23937</ArticleId><ArticleId IdType="pmc">PMC3785076</ArticleId><ArticleId IdType="pubmed">23686809</ArticleId></ArticleIdList></Reference><Reference><Citation>Torok J, Maia PD, Powell F, Pandya S, Raj A. A method for inferring regional origins of neurodegeneration. Brain. 2018;141(3):863&#x2013;76. doi: 10.1093/brain/awx371</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awx371</ArticleId><ArticleId IdType="pmc">PMC5837438</ArticleId><ArticleId IdType="pubmed">29409009</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>